Fasting Comparative Bioavailability Study of 2 Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition
Clinical trial NCT05125588 · COMPLETED
Trial details
- NCT number
- NCT05125588
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-29
- Primary completion
- 2014-02-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.